A Novel Complex Regulates cardiac actin Gene Expression through Interaction of Emb, a Class VI POU Domain Protein, MEF2D, and the Histone Transacetylase p300

REFERENCES

• Andersen, B., Schonemann M. D., Pearse R. V., Jenne K., Sugarman J., and Rosenfeld M. G.. 1993. Bnr 5 is a divergent POU domain factor highly expressed in layer IV of the neocortex. J. Biol. Chem. 268:23390–23398.
   PubMedGoogle Scholar
• Biben, C., Kirschbaum B. J., Garner L., and Buckingham M.. 1994. Novel muscle-specific enhancer sequences upstream of the cardiac actin gene. Mol. Cell. Biol. 14:3504–3513.
   PubMedGoogle Scholar
• Biben, C., Hadchouel J., Tajbakhsh S., and Buckingham M.. 1996. Developmental and tissue-specific regulation of the murine cardiac actin gene in vivo depends on distinct skeletal and cardiac muscle-specific enhancer elements in addition to the proximal promoter. Dev. Biol. 173:200–212.
   PubMedGoogle Scholar
• Black, B. L., and Olson E. N.. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167–196.
   PubMed Web of Science ®Google Scholar
• Buckingham, M., and Tajbakhsh S.. 1999. Myogenic cell specification during somitogenesis, p. 617–633. In Moody S. A. (ed.), Cell lineage and fate determination. Academic Press, New York, N.Y.
   Google Scholar
• Catala, F., Wanner R., Barton P., Cohen A., Wright W., and Buckingham M.. 1995. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene. Mol. Cell. Biol. 15:4585–4596.
   PubMed Web of Science ®Google Scholar
• Chen, S. L., Dowhan D. H., Hosking B. M., and Muscat G. E.. 2000. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev. 14:1209–1228.
   PubMedGoogle Scholar
• Cui, H., and Bulleit R. F.. 1997. Expression of the POU transcription factor Brn-5 inhibits proliferation of NG108-15 cells. Biochem. Biophys. Res. Commun. 236:693–696.
   PubMedGoogle Scholar
• Cui, H., and Bulleit R. F.. 1998. Expression of the POU transcription factor Brn5 is an early event in the terminal differentiation of CNS neurons. J. Neurosci. Res. 52:625–632.
   PubMedGoogle Scholar
• Czerjesi, P., Lilly B., Hinkley C., Perry M., and Olson E. N.. 1994. Homeodomain protein MHox and MADS protein myocyte enhancer-binding factor-2 converge on a common element in the muscle creatine kinase enhancer. J. Biol. Chem. 269:16740–16745.
   PubMedGoogle Scholar
• Dhalluin, C., Carlson J. E., Zeng L., Cheng H., Aggarwal A. K., and Zhou M. M.. 1999. Structure and ligand of a histone acetyltransferase bromodomain. Nature 399:491–496.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., Lebovitz R. M., and Roeder R. G.. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Di Lisi, R., Millino C., Calabria E., Altruda F., Schiaffino S., and Ausoni S.. 1998. Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo. J. Biol. Chem. 273:25371–25380.
   PubMedGoogle Scholar
• Dominov, J. A., and Miller J. B.. 1996. POU homeodomain genes and myogenesis. Dev. Genet. 19:108–118.
   PubMedGoogle Scholar
• Dressel, U., Bailey P. J., Wang S. C., Downes M., Evans R. M., and Muscat G. E.. 2001. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J. Biol. Chem. 276:17007–17013.
   PubMed Web of Science ®Google Scholar
• Eckner, R., Yao T. P., Oldread E., and Livingston D. M.. 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478–2490.
   PubMed Web of Science ®Google Scholar
• Ferrari, S., Battini R., and Molinari S.. 1994. Specific binding to vitamin D response elements of chicken intestinal DNA-binding activity is not related to the vitamin D receptor. Mol. Endocrinol. 8:173–181.
   PubMedGoogle Scholar
• Garner, I., Minty A. J., Alonso S., Barton P. J., and Buckingham M. E.. 1986. A 5′ duplication of the α-cardiac actin gene in BALB/c mice is associated with abnormal levels of α-cardiac and α-skeletal actin mRNAs in adult cardiac tissue. EMBO J. 5:2559–2567.
   PubMedGoogle Scholar
• Garner, I., Sassoon D., Vandekerckhove J., Alonso S., and Buckingham M. E.. 1989. A developmental study of the abnormal expression of α-cardiac and α-skeletal actins in the striated muscle of a mutant mouse. Dev. Biol. 134:236–245.
   PubMedGoogle Scholar
• Gerber, A. N., Klesert T. R., Bergstrom D. A., and Tapscott S. J.. 1997. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 11:436–450.
   PubMedGoogle Scholar
• Gossett, L. A., Kelvin D. J., Sternberg E. A., and Olson E. N.. 1989. A new myocyte-specific enhancer-binding factor that recognizes a conserved element associated with multiple muscle-specific genes. Mol. Cell. Biol. 9:5022–5033.
   PubMed Web of Science ®Google Scholar
• Han, T. H., and Prywes R.. 1995. Regulatory role of MEF2D in serum induction of the c-jun promoter. Mol. Cell. Biol. 15:2907–2915.
   PubMedGoogle Scholar
• Hinkley, C., and Perry M.. 1991. A variant octamer motif in a Xenopus H2B histone gene promoter is not required for transcription in frog oocytes. Mol. Cell. Biol. 11:641–654.
   PubMedGoogle Scholar
• Jaynes, J. B., Johnson J. E., Buskin J. N., Gartside C. I., and Hauschka S. D.. 1988. The muscle creatine kinase gene is regulated by multiple upstream elements, including a muscle-specific enhancer. Mol. Cell. Biol. 8:62–70.
   PubMedGoogle Scholar
• Johansen, T., Moens U., Holm T., Fjose A., and Krauss S.. 1993. Zebrafish pou(c): a divergent POU family gene ubiquitously expressed during embryogenesis. Nucleic Acids Res. 21:475–483.
   PubMedGoogle Scholar
• Kelly, R. G., Zammit P. S., Schneider A., Alonso S., Biben C., and Buckingham M. E.. 1997. Embryonic and foetal myogenic programmes act through separate enhancers at the MLC1F/3F locus. Dev. Biol. 187:183–199.
   PubMedGoogle Scholar
• Kouzarides, T. 2000. Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19:1176–1179.
   PubMed Web of Science ®Google Scholar
• Lakish, M. M., Diagana T. T., North D. L., and Whalen R. G.. 1998. MEF-2 and Oct-1 bind to two homologous promoter sequence elements and participate in the expression of a skeletal muscle-specific gene. J. Biol. Chem. 273:15217–15226.
   PubMedGoogle Scholar
• Lemercier, C., Verdel A., Galloo B., Curtet S., Brocard M. P., and Khochbin S.. 2000. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275:15594–15599.
   PubMed Web of Science ®Google Scholar
• Liu, Q., Schwartz J., Bucana C., and Olson E. N.. 1997. Control of cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404–1407.
   PubMedGoogle Scholar
• Lu, J., McKinsey T. A., Zhang C. L., and Olson E. N.. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233–244.
   PubMed Web of Science ®Google Scholar
• Mal, A., Sturniolo M., Schiltz R. L., Ghosh M. K., and Harter M. L.. 2001. A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20:1739–1753.
   PubMed Web of Science ®Google Scholar
• Martin, J. F., Miano J. M., Hustad C. M., Copeland N. G., Jenkins N. A., and Olson E. N.. 1994. A MEF2 gene that generates a muscle-specific isoform via alternative mRNA splicing. Mol. Cell. Biol. 14:1647–1656.
   PubMed Web of Science ®Google Scholar
• Maxam, A. M., and Gilbert W.. 1980. Sequencing end-labelled DNA with base-specific chemical cleavages. Methods Enzymol. 65:499–560.
   PubMedGoogle Scholar
• McKinsey, T. A., Zhang C. L., and Olson E. N.. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497–504.
   PubMed Web of Science ®Google Scholar
• Messier, H., Brickner H., Gaikwad J., and Fotedar A.. 1993. A novel POU domain protein which binds to the T-cell receptor β-enhancer. Mol. Cell. Biol. 13:5450–5460.
   PubMedGoogle Scholar
• Minty, A. J., Alonso S., Caravatti M., and Buckingham M. E.. 1982. A fetal skeletal muscle actin mRNA in the mouse and its identity with cardiac actin mRNA. Cell 30:185–192.
   PubMed Web of Science ®Google Scholar
• Miska, E. A., Karlsson C., Langley E., Nielsen S. J., Pines J., and Kouzarides T.. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099–5107.
   PubMed Web of Science ®Google Scholar
• Missero, C., Calautti E., Eckner R., Chin J., Tsai L. H., Livingston D. M., and Dotto G. P.. 1995. Involvement of the cell-cycle inhibitor CipI/WAFI and the EIA-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451–5455.
   PubMed Web of Science ®Google Scholar
• Molkentin, J. D., Black B. L., Martin J. F., and Olson E. N.. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125–1136.
   PubMedGoogle Scholar
• Murphy, S., Yoon J. B., Gerster T., and Roeder R. G.. 1992. Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes. Mol. Cell. Biol. 12:3247–3261.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., Wakamiya M., Noji S., Koyama E., Taniguchi S., Takemura R., Copeland N. G., Gilbert D. J., Jenkins N. A., Muramatsu M., and Hamada H.. 1993. A novel class of murine POU gene predominantly expressed in central nervous system. J. Biol. Chem. 268:7449–7457.
   PubMedGoogle Scholar
• Polesskaya, A., Duquet A., Naguibneva L., Weise C., Vervisch A., Bengal E., Hucho F., Robin P., and Harel-Bellan A.. 2000. CREB-binding protein/p300 activates MyoD by acetylation. J. Biol. Chem. 275:34359–34364.
   PubMed Web of Science ®Google Scholar
• Polesskaya, A., Naguibneva L., Fritsch L., Duquet A., Ait-Si-Ali A., Robin P., Vervisch A., Pritchard L. L., Cole P., and Harel-Bellan A.. 2001. CBP/p300 and muscle differentiation: no HAT, no muscle. EMBO J. 20:6816–6825.
   PubMed Web of Science ®Google Scholar
• Pontoglio, M., Faust D. M., Doyen A., Yaniv M., and Weiss M. C.. 1997. Hepatocyte nuclear factor 1α gene inactivation impairs chromatin remodeling and demethylation of the phenylalanine hydroxylase gene. Mol. Cell. Biol. 17:4948–4956.
   PubMedGoogle Scholar
• Puri, P. L., Avantaggiati M. L., Balsano C., Sang N., Graessmann A., Giordano A., and Levrero M.. 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369–383.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., Sartorelli V., Yang X. J., Hamamori Y., Ogryzko W., Howard B. H., Kedes L., Wang J. Y., Graessmann A., Nakatani Y., and Levrero M.. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35–45.
   PubMed Web of Science ®Google Scholar
• Raguz, S., Hobbs C., Yague E., Ioannou P. A., Walsh F. S., and Antoniou M.. 1998. Muscle-specific locus control region activity associated with the human desmin gene. Dev. Biol. 201:26–42.
   PubMedGoogle Scholar
• Relaix, F., Molinari S., Lemonnier M., Schäfer B., and Buckingham M.. The in vivo form of the murine class VI POU protein Emb is larger than that encoded by previously described transcripts. Gene, in press.
   Google Scholar
• Rhee, J. M., Gruber C. A., Brodie T. B., Trieu M., and Turner E. E.. 1998. Highly co-operative homodimerization is a conserved property of neural POU proteins. J. Biol. Chem. 273:34196–34205.
   PubMedGoogle Scholar
• Sartorelli, V., Huang J., Hamamori Y., and Kedes L.. 1997. Molecular mechanisms of myogenic coactivation by p300: indirect interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010–1026.
   PubMed Web of Science ®Google Scholar
• Sartorelli, V., Puri P. L., Hamamori Y., Ogrysko V., Chung G., Nakatani Y., Wang J. Y., and Kedes L.. 1999. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4:725–734.
   PubMed Web of Science ®Google Scholar
• Schreiber, E., Harshman K., Kemler L., Malipiero U., Schaffner W., and Fontana A.. 1990. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 18:5495–5503.
   PubMedGoogle Scholar
• Seed, B., and Sheen J. Y.. 1988. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene 67:271–277.
   PubMed Web of Science ®Google Scholar
• Sive, H. L., and Roeder R. G.. 1986. Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. Proc. Natl. Acad. Sci. USA 83:6382–6386.
   PubMed Web of Science ®Google Scholar
• Slepak, T. I., Webster K. A., Zang J., Prentice H., O'Dowd A., Hicks M. N., and Bishopric N. H.. 2001. Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D. J. Biol. Chem. 276:7575–7585.
   PubMedGoogle Scholar
• Soutoglou, E., Viollet B., Vaxillaire M., Yaniv M., Pontoglio M., and Talianidis I.. 2001. Transcription factor-dependent regulation of CBP and P/CAF histone acetyltransferase activity. EMBO J. 20:1984–1992.
   PubMed Web of Science ®Google Scholar
• Strahl, B. D., and Allis C. D.. 2000. The language of covalent histone modifications. Nature 403:41–45.
   PubMed Web of Science ®Google Scholar
• Sturm, R. A., and Herr W.. 1998. The POU domain is a bipartite DNA binding structure. Nature 336:601–604.
   Google Scholar
• Verrijzer, C. P., Alkema M. J., van Weperen W. W., Van Leeuwen H. C., Strating M. J., and van der Vliet P. C.. 1992. The DNA binding specificity of the bipartite POU domain and its subdomains. EMBO J. 11:4993–5003.
   PubMedGoogle Scholar
• Wang, A. H., Bertos N. R., Vezmar M., Pelletier N., Crosato M., Heng H. H., Th'ng J., Han J., and Yang X. J.. 1999. HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19:7816–7827.
   PubMed Web of Science ®Google Scholar
• West, A. G., Gaszner M., and Felsenfeld G.. 2002. Insulators: many functions, many mechanisms. Genes Dev. 16:271–288.
   PubMed Web of Science ®Google Scholar
• Wey, E., Lyons G. E., and Schäfer B. W.. 1994. A human POU domain gene, mPOU, is expressed in developing brain and specific adult tissues. Eur. J. Biochem. 220:753–762.
   PubMedGoogle Scholar
• Wey, E., and Schäfer B. W.. 1996. Identification of novel DNA binding sites recognized by the transcription factor mPOU (POU 6F1). Biochem. Biophys. Res. Commun. 220:274–279.
   PubMedGoogle Scholar
• Wu, R., Jurek M., Sundarababu S., and Weinstein D. E.. 2001. The POU gene Brn5 is induced by neuregulin and is restricted to myelinating Schwann cells. Mol. Cell Neurosci. 17:683–695.
   PubMedGoogle Scholar
• Xu, W., Edmondson D. G., Evrard Y. A., Wakamiya M., Behringer R. R., and Roth S. Y.. 2000. Loss of Gcn512 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26:229–232.
   PubMedGoogle Scholar
• Yaffé, D., and Saxel O.. 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic muscle. Nature 270:725–777.
   PubMed Web of Science ®Google Scholar
• Yao, T. P., Oh S. P., Fuchs M., Zhou N. D., Ch'ng L. E., Newsome D., Bronson R. T., Li E., Livingstone D. M., and Eckner R.. 1998. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361–372.
   PubMed Web of Science ®Google Scholar
• Yuan, W., Condorelli G., Caruso M., Felsani A., and Giordano A.. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9009–9013.
   PubMed Web of Science ®Google Scholar